FDA's Orange Book Doesn't Include Amarin's Vascepa NCE Status in November Report - Bloomberg

Loading...
Loading...
View
Orange Book
.
Market News and Data brought to you by Benzinga APIs
Posted In: NewsFDA
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...